ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag minorities genetics genomics

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
The Genes of Parkinsonā€™s Disease
Bobby Thomas and M. Flint Beal | Feb 1, 2011 | 10 min read
The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.
The Value of Your Genome
James P. Evans and Jonathan S. Berg | Dec 1, 2012 | 3 min read
Genome sequencing: it’s not for everyone
Recent Trials for Fragile X Syndrome Offer Hope
Randi Hagerman | Sep 1, 2019 | 10+ min read
Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.
Mutation Station: Transgenomic's WAVE System Eliminates Base-by-Base Search
Amy Francis | Sep 26, 1999 | 2 min read
A minor alteration in a single gene of the human body can be a major contributor to the development of a wide spectrum of diseases ranging from cystic fibrosis to cancer. With the Human Genome Project in full swing, the number of genes available to analyze for these changes is growing daily. The increased demand for genetic testing also requires rapid screening capabilities. Transgenomic Inc. recognized this need and has designed an automated high-throughput system for mutation detection. Trans
The Genes of Parkinsons Disease
Bobby Thomas and M. Flint Beal | Feb 1, 2011 | 7 min read
By Bobby Thomas and M. Flint Beal The Genes of Parkinson’s Disease The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure. Gerald Slota It took centuries for the slumped posture, trembling hands, poor balance, and cognitive impairments that characterize Parkinson’s disease (PD) to be recognized as manifest
Trickle-Down Genomics: Reforming ""Small Science"" As We Know It
Edward Smith | Jul 18, 1999 | 7 min read
if (n == null) The Scientist - Trickle-Down Genomics: Reforming ""Small Science"" As We Know It The Scientist 13[15]:19, Jul. 19, 1999 Opinion Trickle-Down Genomics: Reforming "Small Science" As We Know It By Edward J. Smith Each generation attempts to develop programs and activities that help it fulfill the ancient Chinese wish "May you live in interesting times." These are indeed interesting times from the perspective of the biologist: The complete geno
Reductio Ad Amino Acid
Bob Sinclair | Feb 1, 1999 | 10+ min read
Date: February 1, 1999Fusion/Tag Proteases TableProteolytic Enzymes TableTable 3Table 4 A proteome analysis aims to characterize all proteins expressed by an organism or tissue. The next step will be to correlate a protein profile with the appropriate genome, and beyond that researchers will want to understand the correlations between levels of proteins, co- and post-translational modifications, and cell or tissue activity. Many of the technologies that are necessary to realize this goal are de
Bloody Isle
Newamul Khan | Apr 1, 2007 | 3 min read
Bloody Isle When genetics and history compete, who wins?By Newamul Khan ARTICLE EXTRASSPRING BOOKSStem Cells on ShelvesAn Awkward SymbiosisThe Death of Faith?High in the TreesThe Enchantment of EnhancementBooks about BodiesNew Lab ManualsIn Brief Saxons, Vikings, and Celts: The Genetic Roots of Britain and Ireland, By Bryan Sykes, 320
Deviations From The Norm: Systems For Mutation Detection Reveal Hidden Potentials
Kailash Gupta | Jul 18, 1999 | 10+ min read
Date: July 19, 1999Mutation Detection Systems and Methods Affymetrix's p53 chip Researchers leading the Human Genome Project (HGP) originally envisioned completion of the entire genome sequence (approximately 3 billion base pairs) by the year 2005. Recently the arena of human genome sequencing has seen a lot of heat generated by the entry of both commercial entrepreneurs and public consortia. Celera, a company formed by highly skilled and competent commercial organizations (TIGR and Perkin-Elm

Run a Search

ADVERTISEMENT